(Q36466694)

14 August 2017

Hodgkin's disease: subsequent primary cancers in relation to treatment (English)

1 reference

14 August 2017

Prior P

1

1 reference

14 August 2017

Pope DJ

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 October 1988

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

58

1 reference

14 August 2017

4

1 reference

14 August 2017

512-517

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1988.253

14 August 2017

0 references

cites work

Immunity in Hodgkin's disease: status after 5 years' remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Impact of Hodgkin's disease upon the immune system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Hodgkin's disease: long-term effects of therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Second malignancies complicating Hodgkin's disease in remission

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Second primary cancers following treatment of Hodgkin's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Splenectomy in Hodgkin's disease and second leukaemias.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246798

Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy

27 July 2018

1 reference

12 December 2020

Increased sensitivity of T cells to regulation by normal suppressor cells persists in long-term survivors with Hodgkin's disease

1 reference

12 December 2020

Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease

1 reference

12 December 2020

Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease

1 reference

12 December 2020

Increased proportion of suppressor/cytotoxic (OKT8+) cells in patients with Hodgkin's disease in long-lasting remission

1 reference

12 December 2020

Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease

1 reference

12 December 2020

A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease

1 reference

12 December 2020

Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience

1 reference

12 December 2020

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1988.253

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

1 reference